| |
| |
|
| Insider
Information: |
Glenn Gregory M |
| Relationship: |
President, R&D |
| City: |
Gaithersburg |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
18,339 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,593 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
18,339 |
|
|
| Total
Value |
$6,593 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -200.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novavax Inc |
NVAX |
President, R&D |
2023-03-10 |
18,339 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
128 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVAX |
Novavax Inc |
Chief Scientific OfficerOffice |
• – – |
2010-07-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,000 |
|
- |
|
| NVAX |
Novavax Inc |
Chief Scientific Officer |
• – – |
2010-08-25 |
4 |
B |
$2.01 |
$4,018 |
D/D |
2,000 |
2,000 |
2.66 |
- |
|
| NVAX |
Novavax Inc |
Chief Scientific Officer |
• – – |
2011-04-07 |
4 |
S |
$2.56 |
$133,120 |
D/D |
(52,000) |
414,000 |
0 |
- |
|
| NVAX |
Novavax Inc |
Chief Scientific Officer |
• – – |
2011-11-29 |
4 |
B |
$1.26 |
$2,520 |
D/D |
2,000 |
416,000 |
2.66 |
- |
|
| NVAX |
Novavax Inc |
Chief Scientific Officer |
• – – |
2011-12-05 |
4 |
B |
$1.50 |
$3,000 |
D/D |
2,000 |
418,000 |
2.66 |
- |
|
| NVAX |
Novavax Inc |
Chief Scientific Officer |
• – – |
2012-05-10 |
4 |
B |
$1.35 |
$33,750 |
D/D |
25,000 |
29,000 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
Chief Scientific Officer |
• – – |
2013-06-06 |
4 |
B |
$2.01 |
$2,010 |
D/D |
1,000 |
30,000 |
2.66 |
- |
|
| NVAX |
Novavax Inc |
Chief Scientific Officer |
• – – |
2013-06-07 |
4 |
B |
$1.83 |
$1,830 |
D/D |
1,000 |
31,000 |
2.66 |
- |
|
| NVAX |
Novavax Inc |
SVP, Research and Development |
• – – |
2014-01-31 |
4 |
B |
$2.29 |
$9,394 |
D/D |
4,102 |
31,000 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
SVP, Research and Development |
• – – |
2014-03-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
33,102 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, Research and Development |
• – – |
2014-03-14 |
4 |
S |
$5.48 |
$158,778 |
D/D |
(29,000) |
4,102 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, Research and Development |
• – – |
2014-07-31 |
4 |
B |
$2.28 |
$28,972 |
D/D |
12,707 |
16,809 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
SVP, Research and Development |
• – – |
2014-09-26 |
4 |
S |
$4.16 |
$69,929 |
D/D |
(16,809) |
0 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, Research and Development |
• – – |
2015-01-31 |
4 |
B |
$2.28 |
$1,974 |
D/D |
866 |
866 |
2.66 |
- |
|
| NVAX |
Novavax Inc |
SVP, Research and Development |
• – – |
2015-03-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
600 |
266 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, Research and Development |
• – – |
2015-07-31 |
4 |
B |
$2.28 |
$2,034 |
D/D |
892 |
1,158 |
2.66 |
- |
|
| NVAX |
Novavax Inc |
SVP, Research and Development |
• – – |
2015-08-18 |
4 |
OE |
$2.11 |
$31,650 |
D/D |
15,000 |
16,158 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, Research and Development |
• – – |
2015-08-18 |
4 |
S |
$13.52 |
$202,743 |
D/D |
(15,000) |
1,158 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, Research and Development |
• – – |
2015-08-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,100 |
58 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, Research and Development |
• – – |
2015-12-16 |
4 |
S |
$8.58 |
$530,697 |
D/D |
(61,886) |
58 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, Research and Development |
• – – |
2015-12-16 |
4 |
OE |
$1.83 |
$113,251 |
D/D |
61,886 |
61,944 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, Research and Development |
• – – |
2016-01-31 |
4 |
B |
$4.38 |
$10,376 |
D/D |
2,369 |
2,427 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2016-09-21 |
4 |
B |
$1.65 |
$1,649 |
D/D |
1,000 |
3,427 |
2.66 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2016-12-07 |
4 |
B |
$1.45 |
$1,446 |
D/D |
1,000 |
4,427 |
2.66 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2017-11-09 |
4 |
B |
$1.13 |
$11,300 |
D/D |
10,000 |
14,427 |
2.74 |
- |
|
128 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
